PLoS ONE · 2008 · 47 citations · 47 references
Life SciencesCancer BiologyCell BiologyCell AdhesionCell SignalingSignal TransductionAngiogenesisCell-matrix AdhesionIntegrin SignalingPlatelet ActivationPlatelet FunctionPlatelet PhysiologyAdhesion ReceptorsEndothelial Cell AdhesionIntegrin BindingIntegrin ReceptorsIntegrin-binding LigandsIntegrin-ligand BindingIntegrin-mediated Cell AdhesionPlatelet Alpha Granules
The human CXC-chemokine CXCL4 is a potent inhibitor of tumor-induced angiogenesis. Considering that CXCL4 is sequestered in platelet alpha-granules and released following platelet activation in the vicinity of vessel wall injury, we tested the hypothesis that CXCL4 might function as a ligand for integrins. Integrins are a family of adhesion receptors that play a crucial role in angiogenesis by regulating early angiogenic processes, such as endothelial cell adhesion and migration. Here, we show that CXCL4 interacts with alphavbeta3 on the surface of alphavbeta3-CHO. More importantly, human umbilical vein endothelial cells adhere to immobilized CXCL4 through alphavbeta3 integrin, and also through other integrins, such as alphavbeta5 and alpha5beta1. We further demonstrate that CXCL4-integrin interaction is of functional significance in vitro, since immobilized CXCL4 supported endothelial cell spreading and migration in an integrin-dependent manner. Soluble CXCL4, in turn, inhibits integrin-dependent endothelial cell adhesion and migration. As a whole, our study identifies integrins as novel receptors for CXCL4 that may contribute to its antiangiogenic effect.
47
Definition of Two Angiogenic Pathways by Distinct α <sub>v</sub> Integrins
Martin Friedlander, Peter C. Brooks, Robert W. Shaffer et al. · Science · 1995 · 1.3K citations
Laura Lasagni, Michela Francalanci, Francesco Annunziato et al. · The Journal of Experimental Medicine · 2003 · 747 citations · Full text
Medicine, Cancer Biology, Oncology +14